Interdisziplinäre multimodale Schmerztherapie bei Kopfschmerzerkrankungen
暂无分享,去创建一个
[1] F. Rimmele,et al. Medication adherence in patients with cluster headache and migraine: an online survey , 2023, Scientific Reports.
[2] T. Dresler,et al. [Adherent pain patients: How to encourage them]. , 2023, MMW Fortschritte der Medizin.
[3] S. Sacco,et al. Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis , 2023, The Journal of Headache and Pain.
[4] A. May,et al. Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline , 2022, Neurological Research and Practice.
[5] L. Grazzi. Mindfulness and other behavioral approaches , 2022, Neurological Sciences.
[6] J. Sico,et al. Cluster Headache: Clinical Characteristics and Opportunities to Enhance Quality of Life , 2021, Current Pain and Headache Reports.
[7] U. Niederberger,et al. Wirkungsweise und Anwendung des Biofeedbacks am Beispiel von Kopfschmerzen , 2021, Psychotherapeut.
[8] A. Khosravi,et al. Biofeedback: An Effective Add-on Treatment for Migraine Headache Alongside Medication Therapy , 2021 .
[9] T. Dresler,et al. [Psychological procedures in headache therapy: what is the evidence?] , 2021, MMW Fortschritte der Medizin.
[10] E. Loder,et al. Effectiveness of Mindfulness Meditation vs Headache Education for Adults With Migraine: A Randomized Clinical Trial. , 2020, JAMA internal medicine.
[11] T. Steiner,et al. Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019 , 2020, The Journal of Headache and Pain.
[12] R. Lipton,et al. Smartphone‐Delivered Progressive Muscle Relaxation for the Treatment of Migraine in Primary Care: A Randomized Controlled Trial , 2020, Headache.
[13] T. Hinterberger,et al. [Effectiveness of Biofeedback for Primary Headache - A Randomized Controlled Study]. , 2020, Psychotherapie, Psychosomatik, medizinische Psychologie.
[14] R. Ruscheweyh,et al. Multimodale Programme und neue Therapien gegen den Kopfschmerz , 2019, DNP - Der Neurologe & Psychiater.
[15] M. Dahlem,et al. [What do migraine apps offer?] , 2018, MMW Fortschritte der Medizin.
[16] B. Meyer,et al. Entspannungsverfahren und verhaltenstherapeutische Interventionen zur Behandlung der Migräne , 2017, Nervenheilkunde.
[17] P. Kropp,et al. Progressive muscle relaxation reduces migraine frequency and normalizes amplitudes of contingent negative variation (CNV) , 2016, The Journal of Headache and Pain.
[18] R. Klinger,et al. Die Erwartungshaltung — Migräneauslöser Nummer 1? , 2015, MMW - Fortschritte der Medizin.
[19] A. Paris‐Alemany,et al. Effectiveness of therapeutic patient education for adults with migraine. A systematic review and meta-analysis of randomized controlled trials. , 2014, Pain medicine.
[20] M. Marziniak,et al. Konsensuspapier der Deutschen Migräne- und Kopfschmerzgesellschaft zur Struktur von Kopfschmerzzentren und Kopfschmerzschwerpunktpraxen in Deutschland , 2014, Der Schmerz.
[21] S. Powers,et al. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. , 2013, JAMA.
[22] B. Kröner-Herwig,et al. Psychologische Therapie der Migräne , 2013, Der Schmerz.
[23] P. Kropp,et al. Multidisciplinary integrated headache care: a prospective 12-month follow-up observational study , 2012, The Journal of Headache and Pain.
[24] F. Andrasik. Behavioral treatment of headaches: extending the reach , 2012, Neurological Sciences.
[25] H. Diener,et al. Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study , 2011, The Journal of Headache and Pain.
[26] H. Diener,et al. Prevention of medication overuse in patients with migraine , 2010, PAIN®.
[27] K. Holroyd,et al. Effect of preventive (β blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial , 2010, BMJ : British Medical Journal.
[28] K. Holroyd,et al. Dynamics of Changes in Self-Efficacy and Locus of Control Expectancies in the Behavioral and Drug Treatment of Severe Migraine , 2010, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.
[29] R. Lipton,et al. Consistency of Response to Sumatriptan/Naproxen Sodium in a Placebo-Controlled, Crossover Study , 2009, Cephalalgia : an international journal of headache.
[30] F. Andrasik,et al. Behavioral plus pharmacological treatment versus pharmacological treatment only for chronic migraine with medication overuse after day-hospital withdrawal , 2009, Neurological Sciences.
[31] G. Lenzi,et al. Combined Pharmacological and Short-Term Psychodynamic Psychotherapy for Probable Medication Overuse Headache: A Pilot Study , 2009, Cephalalgia : an international journal of headache.
[32] J. Rothrock,et al. The Impact of Intensive Patient Education on Clinical Outcome in a Clinic‐Based Migraine Population , 2006, Headache.
[33] R. Lipton,et al. The Family Impact of Migraine: Population-Based Studies in the USA and UK , 2003, Cephalalgia : an international journal of headache.
[34] F. Andrasik,et al. Behavioral and Pharmacologic Treatment of Transformed Migraine With Analgesic Overuse: Outcome at 3 Years , 2002, Headache.
[35] K. Holroyd,et al. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. , 2001, JAMA.
[36] K. Holroyd,et al. Perceived Self‐efficacy and Headache‐Related Disability , 2000, Headache.
[37] T. Klan,et al. Kognitiv-verhaltenstherapeutisches Migränemanagement (MIMA) , 2020 .
[38] M. Arnold. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition , 2018, Cephalalgia : an international journal of headache.
[39] M. Litt. Mediating factors in non-medical treatment for migraine headache: toward an interactional model. , 1986, Journal of psychosomatic research.